Jason Drew Smith - 05 Jun 2021 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
General Counsel
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
05 Jun 2021
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 14:33:56 UTC
Previous filing
18 May 2021
Next filing
02 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 05 Jun 2021 Common Stock 15,000 $17.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares underlying the stock options will vest on each of June 1, 2022, June 1, 2023 and June 1, 2024.